Topic prioritisation

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Decision date

Decision date

Decision

Decision

Prioritisation programme

Prioritisation programme

Showing 1 to 10 of 389

TitlePrioritisation programmeDecisionDecision date
Ruxolitinib for treating acute graft-versus-host disease after allogeneic stem cell transplant in people 28 days to 17 years [ID6410]Medicines evaluationNot selected
Siponimod for treating multiple sclerosis in people 10 to 17 years [TSID12317]Medicines evaluationNot selected
Pegunigalsidase alfa every 4 weeks for treating Fabry disease [TSID12346]Medicines evaluationNot selected
Sirolimus gel for treating facial angiofibroma from tuberous sclerosis complex in people 6 years and older (review of TA972) [ID6757]None selectedAwaiting decision
Peginterferon alfa-2a for treating polycythaemia vera or essential thrombocythaemia [TSID12325]Medicines evaluationNot selected
Dabrafenib with trametinib for adjuvant treatment of resected BRAF V600 mutation-positive melanoma in people aged 12 to 17 [TSID11839]Medicines evaluationNot selected
Dronabinol for treating muscle spasticity in multiple sclerosis after 2 treatments [TSID10638]Medicines evaluationNot selected
Dabrafenib for treating unresectable or metastatic BRAF V600 mutation positive melanoma in people 12 to 17 years [TSID12399]Medicines evaluationNot selected
Dabrafenib with trametinib for treating unresectable or metastatic BRAF V600 mutation positive melanoma in people 12 to 17 years [TSID12398]Medicines evaluationNot selected
Wireless breast lesion localization using Savi Scout seedInterventional proceduresAwaiting decision

Results per page

  1. 10
  2. 25
  3. 50
  4. All